Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study
The findings “offer pretty compelling evidence that apixaban is the better drug,” a researcher says.
Source: tctmd.com
Stay updated with breaking news from Bleeding Risks With. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The findings “offer pretty compelling evidence that apixaban is the better drug,” a researcher says.